Induction of hypersensitivity to endotoxin lethality in mice by treatment with trehalose 6,6′-dimycolate but not with 2,3,6,6′-tetraacyl trehalose 2′-sulfate

Innate Immunity

Volumn 5, Issue 1-2, 1999, Pages 23-30

  Watanabe, Kenji ^a,b   Hasunuma, Ryoichi ^b   Horikoshi, Tomoko ^b   Yamana, Hironobu ^b   Maruyama, Hiroko ^b   Fujiwara, Nagatoshi ^a   Kumazawa, Yoshio ^b   Yano, Ikuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958229355     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/09680519990050011601     Document Type: Article

References (28)

1. Morrison DC, Ryan JL Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417-432.
2. Suter E., Ullman GE, Hoffman RG Sensitivity of mice to endotoxin after vaccination with BCG (Bacillus Calmette-Gu-rin). Proc Soc Exp Biol Med 1958; 99: 167-169.
3. Howard JG, Biozzi G., Halpern BN, Stiffel C., Mouton D. The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection. Br J Exp Pathol 1959; 40: 281-290.
4. Ribi EE, Cantrell JL, Von Eschen KB, Schwartzman M. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Cancer Res 1979; 39: 4756-4759.
5. Chedid LA, Parant MA, Audibert FMet al.Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun 1982; 35: 417-424.
6. Takada H., Galanos C. Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treatedmice. Infect Immun 1987; 55: 409-413.
7. Parant M., Parant F., Vinit M-A., Jupin C., Noso Y., Chedid L. Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice. J Leukoc Biol 1990; 47: 164-169.
8. Kaneda K., Sumi Y., Kurano F., Kato Y., Yano I. Granuloma formation and hemopoiesis induced by C36-49-mycolic acid-containing glycolipids from Nocardia rubra. Infect Immun 1986; 54: 869-875.
9. Natsuhara Y., Oka S., Kaneda K., Kato Y., Yano I. Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships. Cancer Immunol Immunother 1990; 31: 99-106.
10. Yano I., Tomiyasu I., Kitabatake S., Kaneda K. Granuloma forming activity of mycolic acid-containing glycolipids in Nocardia and related taxa. Acta Leprologica 1984; 2: 341-349.
11. Ozeki Y., Kaneda K., Fujiwara N., Morimoto M., Oka S., Yano I. In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6′-dimycolate). Infect Immun 1997; 65: 1793-1799.
12. Tabata A., Kaneda K., Watanabe H., Abo T., Yano I. Kinetics of organ-associated natural killer cells and intermediate CD3 cells during pulmonary and hepatic granulomatous inflammation induced by mycobacterial cord factor. Microbiol Immunol 1996; 40: 651-658.
13. Parant M., Parant F., Chedid L.et al.Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6′-trehalose dimycolate). J Infect Dis 1977; 135: 771-777.
14. Parant M., Audibert F., Parant F.et al.Nonspecific immunostimulant activities of synthetic trehalose-6,6′-diesters (lower homologs of cord factor). Infect Immun 1978; 20: 12-19.
15. 80 or longer-chain α-mycolic acids in Mycobacterium spp. by gas chromatography-mass spectrometry and mass chromatography. J Clin Microbiol 1986; 24: 1060-1070.
16. Yarkoni E., Rapp H.J. Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6,6′-dimycolate (cord factor). Infect Immun 1979; 24: 571-572.
17. Goren MB, Grange JM, Aber VR, Allen BW, Mitchison DA Role of lipid content and hydrogen peroxidase susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis. Br J Exp Pathol 1982; 63: 693-700.
18. Kumazawa Y., Freudenberg M A., Hausmann C.et al.Formation of interferon-gamma and tumor necrosis factor in mice during Salmonella typhimurium infection. Pathobiology 1991; 59: 194-196.
19. Morita H., Hasunuma R., Hoshino M.et al.Difference in clearance of exogenously administered smooth-form LPS following host responses among normal, sensitized and LPS-tolerant mice. J Endotoxin Res 1997;4: 415-423.
20. Slade SJ, Langhorne J. Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 1989; 179: 353-365.
21. Freudenberg MA, Kumazawa Y., Meding S., Langhorne J., Galanos C. Gamma interferon production in endotoxin-responder and non-responder mice during infection. Infect Immun 1991; 59: 3484-3491.
22. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
23. Vidal SM, Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73: 469-485.
24. Goto Y., Nakamura RM, Takahashi H., Tokunaga T. Genetic control of resistance to Mycobacterium intracellular infection in mice. Infect Immun 1984; 46: 135-140.
25. Mortatti RC, Maia Lcs. Immune response to BCG-Moreau (Rio de Janeiro) strain. Spectrum of delayed hypersensitivity in genetically defined mice. FEMS Microbiol Immunol 1989; 47: 491-498.
26. Pabst MJ, Gross JM, Brozna JP, Goren MB Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J Immunol 1988; 140: 634-640.
27. Galanos C., Freudenberg MA, Katschinski T., Salomao R., Mossmann H., Kumazawa Y. Tumor necrosis factor and host response to endotoxin. In: Morrison DC, Ryan JL, eds. Bacterial Endotoxic Lipopolysaccharides, Vol. II, Bocca Raton: CRC Press, 1992; 75-104.
28. + T lymphocytes. Eur J Immunol 1997; 27: 183-188.